OtoNexus Medical Technologies

OtoNexus Medical Technologies is pioneering a novel diagnostic solution for Otitis Media, a common and often inaccurately treated pediatric infection. Its core innovation is a miniaturized, through-air ultrasound system integrated into an otoscope, providing clinicians with objective data at the point of care to guide antibiotic stewardship. The company has a clear razor-and-blade commercial model, strong patent protection with over 76 patents, and is benefiting from structured regulatory engagement via the FDA STeP program. With a large addressable market and potential for platform expansion, OtoNexus is positioned to address a significant clinical and economic need in frontline care settings.

Proprietary through-air ultrasound, miniaturized to fit within an otoscope speculum tip, designed to directly detect middle ear effusion and help characterize infection type at the point of care.

OtoNexus operates in a unique niche, as no current point-of-care device directly characterizes middle ear effusion with ultrasound. However, it competes indirectly with standard diagnostic tools like traditional otoscopes, tympanometers, and acoustic reflectometers, which are entrenched in clinical practice. Established medical device companies in the ENT space could potentially develop or acquire competing technologies if the market proves attractive.